Subscribe to Search results

The North East Thames RTC (Brentwood) ceased to act as a wholesaler for BPL products.

Published on:

In his letter to Dr William Maycock, Dr Jack Darnborough rejected the idea of distributing Factor 8 on a supra-regional basis and of RTCs distributing commercial Factor 8 as well as NHS Factor 8 and cryoprecipitate.

Published on:

Dr Jack Darnborough agreed to organise the purchase and distribution of commercial Factor 8. He noted one of the reasons for his change of mind as being his knowledge that a haematologist in his region had been purchasing large quantities of commercial Factor 8, costing between £8,000 and £10,000 a year.

Published on:

Dr William Maycock convinced Dr Jack Darnborough of the advantages of distributing commercial Factor 8.

Published on:

Barry Barber, sales manager at Cutter Laboratories, informed Dr Jack Darnborough (Cambridge RTC), about a request to tender for the next Factor 8 contract.

Published on:

Dr Jack Darnborough (Director, East Anglian Blood Transfusion Centre) met with a representative from Cutter Laboratories to discuss the supply of Koate.

Published on:

The Yorkshire RTC did not purchase, store or distribute commercial Factor 8 prior to 1981, but discussions were had with the Regional Health Authority around July 1981 regarding future policy in this matter.

Published on:

The Yorkshire RTC adopted regional purchase of all blood products.

Published on:

The Yorkshire RTC began centrally purchasing Factor 8 on behalf of haemophilia units in Yorkshire based on their individual requests.

Published on:

By January 1981, the West Midlands RTC had established the practice of holding and issuing all Factor 8 products.

Published on:

Dr Bird confirmed to Stan Godfrey that the West Midlands RTC held regional stocks of commercial Factor 8 concentrates purchased by the Regional Health Authority on the basis of calculated regional requirements and said the scheme "works very well".

Published on:

Dr Ala (Birmingham RTC) met with Linda Frith (Cutter Laboratories) to discuss the purchase of Koate HT, Albumin and Gamimune N.

Published on:

Jennifer Cole OBE

Published on:

Dr Harold Gunson cancelled all orders for BPL's non-heat-treated products for January to March 1985, citing the decision in his region to use only heat-treated commercial Factor 8 concentrate.

Published on:

A proposal from Dr Harold Gunson to the Chairman of the North Western Regional Health Authority showed that the North Western Regional Health Authority directly funded the purchase of commercial Factor 8 products supplied to the region's haemophilia centres.

Published on:

Stan Godfrey wrote to all regional transfusion directors to enquire which RTCs currently held all Factor 8 concentrate supplies for distribution.

Published on:

According to Dr Jack Darnborough's letter to Stan Godfrey dated 3 August 1981, the East Anglia RTC held all the region's Factor 8 supplies from 1 April 1977.

Published on:

Dr Jack Darnborough told Stan Godfrey that the purchase of commercial Factor 8 in East Anglia was funded by the region's transfusion centre, with "a fair degree of flexibility agreed" with the region's health authority.

Published on:

At a meeting of the UK Regional Haemophilia Centre Directors' Committee, Dr Kernoff attributed the lack of uptake of 8Y by some centres to the complicated ordering system.

Published on:

PFC supplied the Factor 8 allocated to Northern Ireland to the Belfast RTC, who then in turn supplied it to Dr Mayne.

Published on: